SCHEMBL17680359

SCHEMBL17680359

CCCc1cccc2nc(-c3cc(C)cc(C)c3)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 6/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PDE10A Q9Y233 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13732292 0.85 NOS3 (0.39) TLR8KDM4EALDH1A1GAAMEN1
SCHEMBL17666818 0.83 CDK9 (0.35) TLR8KDM4EALDH1A1MEN1NPC1
SCHEMBL13731884 0.82 GRM2 (0.35) ALDH1A1GAAHPGDNPC1LMNA
SCHEMBL10319231 0.81 DHODH (0.40) KDM4EALDH1A1MEN1NPC1LMNA
SCHEMBL18708642 0.81 ELANE (0.41) KDM4EALDH1A1GAAHPGDCTSS
SCHEMBL24513499 0.80 TACR3 (0.36) TLR8KDM4EALDH1A1MEN1NPC1
SCHEMBL17666817 0.80 AR (0.33) TLR8GAAMEN1NPC1LMNA
SCHEMBL18708640 0.80 ELANE (0.40) KDM4EALDH1A1CTSSCTSKMEN1
SCHEMBL29531209 0.80 CYP1A2 (0.43) ALDH1A1MEN1NPC1MAPTRAB9A
SCHEMBL4436178 0.80 CYP1A2 (0.43) ALDH1A1MEN1NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023082897-A1 METAL IRIDIUM COMPLEX AND APPLICATION THEREOF 广东阿格蕾雅光电材料有限公司 2023-05-19 WO disclosed
WO-2022267941-A1 ORGANOMETALLIC IRIDIUM COMPOUND 广东阿格蕾雅光电材料有限公司 2022-12-29 WO disclosed
WO-2022262662-A1 ORGANOMETALLIC COMPOUND, AND APPLICATION THEREOF 四川阿格瑞新材料有限公司 2022-12-22 WO disclosed
US-20180190914-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2018-07-05 US disclosed
US-20170352821-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-12-07 US disclosed
US-9799838-B2 Fluorinated organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2017-10-24 US disclosed
US-20160285013-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-09-29 US disclosed
US-9397302-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2016-07-19 US disclosed
US-20160104848-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170352821-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ORC3, OCIAD1, ICOSLG TLR8 2238/4885KDM4E 3088/4885ALDH1A1 2142/4885
US-20180190914-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ORC3, OCIAD1, ICOSLG TLR8 2238/4885KDM4E 3088/4885ALDH1A1 2142/4885
US-20160104848-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ORC3, FARS2, FARSA TLR8 4246/4885KDM4E 3162/4885ALDH1A1 1829/4885
US-20160285013-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ORC3, FARS2, FARSA TLR8 4246/4885KDM4E 3162/4885ALDH1A1 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.